Clinical exigencies, psychosocial realities: negotiating HIV preâ  exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada by Newman, Peter A et al.
RESEARCH ARTICLE
Clinical exigencies, psychosocial realities: negotiating HIV
pre-exposure prophylaxis beyond the cascade among gay,
bisexual and other men who have sex with men in Canada
Peter A Newman1§ , Adrian Guta2 , Ashley Lacombe-Duncan1,3 and Suchon Tepjan1
§Corresponding author: Peter A Newman, Factor-Inwentash Faculty of Social Work, University of Toronto, Toronto, Ontario M5S1Y4, Canada. Tel: +1 416 946 8611.
(p.newman@utoronto.ca)
Abstract
Introduction: Notwithstanding the efficacy of oral pre-exposure prophylaxis (PrEP) in clinical trials, a number of obstacles exist
to achieving population-level impact among gay, bisexual and other men who have sex with men (GBM). However, few studies
have explored the subjective experiences of GBM PrEP users and non-users in the community, outside of clinical trials. The
objectives of this study were to explore GBM’s experiences of considering, accessing and using (or not using) PrEP, and to
understand emerging sexual health, social and community issues among GBM in the PrEP era.
Methods: From October 2015 to March 2016, we purposively sampled PrEP-na€ıve and PrEP-experienced GBM from commu-
nity organizations and health centres in Toronto, Canada. In-depth, 45- to 90-minute semi-structured interviews explored PrEP
perspectives and decision-making, access, initiation, use over time, sexual practices and psychosocial considerations. Interviews
were recorded, transcribed verbatim, uploaded into NVIVO, reviewed using thematic analysis and then contrasted with the
PrEP cascade.
Results: Participants included PrEP users (n = 15) and non-users (n = 14) (mean age = 36.7 years; SD = 8.2), largely gay-
identified (86.2%), cisgender male (89.7%) and white (79.3%). Themes indicate not only correspondences, but also limitations
of the PrEP cascade by complicating a user/non-user binary and challenging the unilateral presupposition that HIV risk percep-
tion leads to PrEP acceptance. Findings further call into question assumptions of a linear stage progression and retention in
care as a universal endpoint, instead revealing alternate trajectories of seasonal or intermittent PrEP use and, for some, an
end goal of terminating PrEP. GBM’s narratives also revealed potent psychological/affective experiences of untethering sex
from HIV anxiety; multifaceted PrEP stigma; and challenges to sexual norms and practices that complicate existing behavioural
prevention strategies and sexual and social relationships.
Conclusions: An expanded PrEP cascade should consider alternate trajectories of use based on dynamic relationships and
behavioural risks that may call for seasonal or intermittent use; systemic barriers in access to and sustaining PrEP; and multi-
ple end goals including PrEP maintenance and discontinuation. Incorporating GBM’s lived experiences, evolving preferences,
and psychosocial and community-level challenges into PrEP implementation models, rather than a circumscribed biomedical
approach, may more effectively support HIV prevention and GBM’s broader sexual and psychological health.
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1 | INTRODUCTION
Notwithstanding the efficacy of oral pre-exposure prophylaxis
(PrEP) [1] and its approval in the US [2], Canada and other
jurisdictions [3], a number of obstacles exist to achieving pop-
ulation-level impact among gay, bisexual and other men who
have sex with men (GBM) [4-8]. In response to these chal-
lenges, several models of a PrEP “cascade” or continuum of
care have been developed [7,9,10] that outline major steps in
implementation, from health systems (e.g. identification of
high-risk GBM, screening PrEP candidates, linkage to care,
etc.) and individual perspectives (e.g. perception of HIV risk,
awareness of PrEP, access to healthcare, etc).
A number of quantitative studies have identified gaps
across the cascade: missed opportunities in translating PrEP
interest into initiation [5], racial disparities in initiation
[11,12] and drop-offs (or “failures”) at each stage [9,10,13].
Quantitative metrics have also been applied to assess indi-
vidual’s PrEP knowledge, awareness, willingness and inten-
tions to use PrEP [14-18], and correlates of uptake [5],
with extensive attention to potential “risk compensation”
[2,7,19,20].
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Reflective of a general shift to an HIV prevention paradigm
dominated by biomedical approaches [21-23], few studies
have explored the subjective experiences of GBM in navigat-
ing PrEP. Several qualitative studies have explored perspec-
tives of “PrEP-na€ıve” GBM [24-27]. Qualitative investigations
with PrEP-experienced GBM have largely been conducted in
the context of clinical trials or demonstration projects [19,28-
34], with supports for uptake (e.g. no-cost PrEP, assistance
navigating insurance coverage) and adherence (e.g. financial
incentives, counselling), among GBM who may be character-
ized as early adopters. Scant qualitative research has been
conducted with GBM PrEP users and non-users in community
settings [35]. Understanding real-world experiences of PrEP,
including the meanings with which it is imbued, its impact on
sexual practices, relationships and GBM communities, may
have significant implications for its clinical deployment in a
“PrEP cascade” – and its impact in the real world beyond clini-
cal trials [21,22,36,37].
The objectives of this study were (1) to explore, in depth,
the experiences of GBM in considering, accessing and using
(or not using) PrEP; and (2) to understand emerging sexual
health, social and community issues among GBM in the PrEP
era.
2 | METHODS
2.1 | Study design and sample
From October 2015 to March 2016, we conducted an
exploratory qualitative study to understand the experiences of
PrEP users and non-users in Toronto, Canada. We used pur-
posive sampling based on participants’ self-identifying as
GBM, and as PrEP users or non-users who had thought about
PrEP. Recruitment was conducted by posting flyers in commu-
nity venues serving GBM and through word-of-mouth.
2.2 | Data collection
Data were collected using a brief, self-administered socio-
demographic questionnaire and in-depth semi-structured 45-
to 90-minute interviews. Questionnaire items included demo-
graphics and insurance status (i.e. coverage for PrEP). Face-to-
face interviews explored sexual health and relationships, PrEP
knowledge, access and decision-making; and additionally, for
PrEP users, experiences with initiation, engagement with care,
taking PrEP and long-term goals; and for PrEP non-users,
anticipated comfort accessing PrEP and sexual practices. Inter-
views were conducted (by AG) at a private office at the
University of Toronto or a mutually agreed upon public loca-
tion.
2.3 | Data analysis
We used Fisher’s exact tests to assess demographic differ-
ences between PrEP users and non-users. Interviews were
audio-recorded, transcribed verbatim, uploaded into NVIVO
(NVIVO: QSR International Pty Ltd, version 10.0, Burlington,
MA, USA) and coded using thematic analysis [38,39]. Each
transcript was coded independently by two investigators (AG
and ALD). After reading and re-reading the transcripts for
familiarization, we inductively generated initial codes through
a process of open coding in which we tagged segments of
text that represented underlying themes. ALD and AG met
biweekly during the coding process to compare codes and
discuss emerging themes. A third coder (ST) then conducted
secondary coding of select transcripts. Finally, ALD, AG and
PAN reviewed the themes and determined major themes
that emerged from the data. Differences in coding and
themes were resolved by consensus. Rigour was established
through memoing (i.e. reflective note-taking), negative case-
finding and creation of an audit trail (i.e. to document
research activities and decisions made in the analytic pro-
cess) [40,41]. Lastly, we interfaced themes with the PrEP
cascade to identify correspondences, dissonances, and psy-
chological/affective and social phenomena that may impact on
PrEP implementation.
2.4 | Ethical considerations
The study was approved by the Research Ethics Board at the
University of Toronto. All participants provided written
informed consent and received a $30 honorarium.
3 | RESULTS
3.1 | Participant demographics
Participants’ (n = 29) mean age was 36.7 years (SD = 8.2).
Most of them self-identified as gay (n = 25; 86.2%), cisgender
male (n = 26; 89.7%) and white (n = 23; 79.3%). The majority
had some college education or above (n = 24; 82.8%) and
were employed full-time (n = 18; 62.1%). About half had
insurance that covered PrEP (n = 15, 51.7%). By design, par-
ticipants were equally divided between PrEP users (n = 15;
51.7%) and non-users (n = 14; 48.3%). PrEP users were signif-
icantly more likely to identify as gay versus bisexual/queer
and to have insurance that covers PrEP (see Table 1).
Major themes, dimensions and exemplar quotations are pre-
sented below and in Appendix 1. Quotations from participants
are labelled with a participant number, PrEP user or non-user
and age.
3.2 | HIV risk behaviours
Regardless of PrEP use, participants generally described hav-
ing multiple partners, using condoms inconsistently and
employing a range of strategies for managing sexual risk,
including condom use with particular (e.g. non-primary) part-
ners, serosorting and seropositioning. A participant explained,
“I like ‘natural’; I hate condoms” (P9, non-user, 40 years). How-
ever, some participants who opted against PrEP reported con-
sistent condom use and no negative feelings about condoms:
“Yeah, I use condoms religiously” (P25, non-user, 29 years).
3.3 | HIV risk awareness
In the context of pervasive HIV risk behaviours, participants
described sexual anxiety that resulted in cyclical engagement
in sexual risk practices and healthcare: condomless sex, anxi-
ety and HIV testing to confirm their (negative) status, some-
times multiple times per year: “I don’t like that anxiety; you
have sex with someone and then you don’t know if they’re
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positive or what, and then you have to go get tested” (P19,
PrEP user, 48 years).
Some participants who had not initiated PrEP use described
HIV risk behaviours and the use of testing, but demonstrated
low perceived risk and no anxiety about acquiring HIV: “No,
and I’ll tell you why [I don’t use condoms]. I am one of those
true tops. I test every year, if not twice a year; I’m negative”
(P16, non-user, 47 years). Others described eschewing PrEP
based on sexually transmitted infection (STI) risk awareness:
“It’s not some magic pill that prevents you from contracting
any sort of STI” (P25, non-user, 29 years).
Some participants, largely non-users, described concerns
that PrEP use would lead them to increase sexual risk-taking:
“I’d probably be taking a much more laissez-faire attitude
towards safety” (P5, non-user, 47 years); “I saw it as almost
like a Russian roulette approach to having unprotected, risky
sex. . .” (P13, non-user, 38 years). Thus, sexual risk practices
and associated HIV and STI risk awareness were construed by
some GBM as a rationale for not using PrEP.
3.4 | PrEP information seeking
All PrEP users and some non-users reported seeking out
information in scientific (e.g. academic journals) and/or com-
munity-based sources (AIDS service organization websites).
Some did this very intentionally: “I read every single
study. . .every single clinical practice guideline that had been
published” (P10, PrEP user, 27 years). Others indicated
valuing discussion of PrEP and exploring experiences of PrEP
users: “Yes, I did look it up online, but I prefer talking to
someone rather than seeing many things online. I read blogs
of people on PrEP” (P18, PrEP user, 31 years).
3.5 | PrEP access
Lack of insurance coverage for PrEP emerged as a signifi-
cant concern among non-users: “. . .one of the biggest rea-
sons why I am not on PrEP is because I don’t think I’d be
able to afford it” (P4, non-user, 24 years). Another partici-
pant described his partial coverage as a barrier: “It would
actually be difficult for me to access therapies because I
only have 80% drug coverage” (P1, non-user, 33 years).
Some PrEP-na€ıve participants indicated uncertainty about
their insurance coverage.
3.6 | Linkage to PrEP care
Most participants who sought out PrEP did not report barri-
ers in linkage to care nor discriminatory reactions from
healthcare providers. PrEP access was facilitated by an urban
environment with many LGBTQ-friendly services and physi-
cians, many of whom also provide care to people living with
HIV. As participants explained, “I actually sat down and had a
long discussion with my doctor who is here in Toronto and
he’s been working on HIV for decades” (P14, PrEP user,
42 years). Another PrEP user recounted, “So, I saw him [my
doctor], and told him about this. And he just said, ‘so, okay,
you want to go on PrEP?’ ‘Yes.’ That’s it!” (P12, PrEP user,
42 years).
3.7 | Prescribed PrEP
Participants generally described a smooth process of procur-
ing a prescription for PrEP: “. . .when I eventually did go in, it
was really straightforward. . .conversation about why I wanted
to take it” (P20, PrEP user, 30 years). Participants also
recounted positive experiences in pharmacies, which tended
to be in the downtown core, considered LGBTQ-friendly, and
knowledgeable about HIV: “The pharmacist that I see is well-
versed in PrEP. . .” (P10, PrEP user, 27 years).
3.8 | PrEP initiation
PrEP initiation was described with a range of actions, from
taking PrEP immediately, to taking a PrEP selfie, to waiting.
Participants also articulated a range of emotions: feeling
happy, proud, overwhelmed or ambivalent. A participant
noted, “I finally got my ducks in a row to take it, so it felt
pretty good” (P22, PrEP user, 23 years). Another participant
described ambivalence, regret and delayed initiation due to
no longer considering himself to be at risk for HIV infec-
tion:
I kind of convinced myself and took it but then I regretted
it. . . And I kept it in the drawer. Actually, on the very first
day I thought that I would start using it tomorrow, and I
thought maybe next week, maybe the week after. And I
think it’s been like two weeks now and I haven’t used it
Table 1. Participant characteristics among gay, bisexual and
other men who have sex with men (N = 29) in Toronto,
Canada, October 2015 to March 2016
Variable n %
Age (mean, SD; years) 36.7 8.2
Gender
Cisgender man 26 89.7






Person of colour 6 20.7
Education
≤High school 5 17.2
≥Some college 24 82.8
Employment
Full-time 18 62.1
Not full-time 11 37.9
Insurance covers PrEPa
No/do not know 14 48.3
Yes 15 51.7
aPre-exposure prophylaxis (PrEP) users were significantly more likely
to identify as gay (p = 0.042, Fisher’s exact test) and to have insur-
ance that covered PrEP (p = 0.0001, Fisher’s exact test) compared to
PrEP non-users.
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because. . .thinking I stopped hooking up with guys (P29,
PrEP user, 40 years).
Several narratives of PrEP initiation indicated the use of
social media, including engagement in a PrEP group on
Facebook or taking a “PrEP selfie” for online or private use:
“I took a picture; I took a selfie, just like hundreds of other
people have done. . .” (P20, PrEP user, 30 years). These
online experiences may be seen as joining a PrEP commu-
nity of GBM.
3.9 | Adherence to PrEP
PrEP users described various strategies for taking their medi-
cation, often borne of trial-and-error; many reported having
never missed a dose, some occasional missed doses: “I missed
the odd dose for like the night-time ones” (P23, PrEP user,
38 years). Some participants described online groups and
blogs as sources of support in navigating adherence.
Non-PrEP users generally anticipated that adherence would
not be a concern: “I do vitamins every day. I can just add that
to my regimen. . .” (P5, non-user, 47 years). Alternately, a few
identified adherence concerns as a deterrent:
I know it’s just one pill a day, but when I had to start tak-
ing [another drug] and I only took it once a day, I would
forget sometimes. And, it made me start to think, oh my
god, what if I was on HIV meds or PrEP. . . (P4, non-user,
24 years).
When asked about their perspectives on adherence to a
once-daily tablet compared to on-demand PrEP (not yet
approved by Health Canada, but prescribed off label), some
participants described a preference for the stability of a once-
daily tablet given the spontaneous and erratic nature of their
sex lives; others identified a lack of professional guidance
about how to use an on-demand regimen.
3.10 | Retention/discontinuation
Among fifteen participants who received prescriptions for
PrEP, eleven (73.3%) were retained in PrEP care: one partici-
pant never started taking it and three reported stopping PrEP
use – two intermittently (four to six weeks) and one com-
pletely. Those who ceased taking PrEP described weighing the
risks and benefits, including financial costs during periods of
low levels of sexual activity:
I don’t know what it adds up to [per pill], but I was really
sick for five or six weeks. I just stopped taking it because
I’m not going to hook up so I’m just going to stop, and then
I started again when I started feeling better (P26, PrEP
user, 34 years).
Several participants described their anticipated PrEP use
timeframe as “indefinitely” (P24, PrEP user, 31 years), “until I
die” (P7, PrEP user, 45 years) and “there is no way I can go
off it” (P23, PrEP user, 38 years). Others perceived using
PrEP for a limited time, reporting their PrEP use may change
due to relationship status (e.g. entering a monogamous rela-
tionship) or insurance coverage (e.g. losing a job).
PrEP users largely did not report concerns, and several indi-
cated benefits, around ongoing HIV testing and engagement
with care: “I think getting tested regularly as a community is
one of the best ways to reduce new STI transmission” (P20,
PrEP user, 30 years). When asked about possible alternatives,
both PrEP users and non-users expressed interest in inject-
able PrEP, perceived as offering protection without daily
adherence and eliminating the psychological burden of every-
day antiretroviral use: “I think that would be cool, and then
you could just forget about it, because I think it could be psy-
chological for some people” (P28, non-user, 28 years). All par-
ticipants hoped for long-term protection from an efficacious
HIV vaccine, described as “ideal.”
3.11 | PrEP stigma
Participant narratives revealed acute awareness of stigma
associated with PrEP use (and users) and GBM’s sexuality
more broadly, evidenced among PrEP users and non-users.
Vicarious stigma was revealed in assumptions about PrEP
users, including reading and hearing stories, especially online:
“The internet and the apps are opportunities to be really cruel
for many people” (P1, non-user, 33 years). A PrEP user simi-
larly described the Internet as a vehicle for stigma, but also
challenging such judgements:
He [a friend online] was very judgmental. His post was ‘peo-
ple [on PrEP] are disgusting.’ I said, listen, I bareback and I
don’t think I’m a disgusting, horrible person; so, I don’t
understand why this is an issue when you consider me to
be your friend (P7, PrEP user, 45 years).
Negative representations of PrEP users constrained some
participants from disclosing their PrEP use due to fears of
being judged as “promiscuous” or “barebackers” (felt-norma-
tive stigma); this evoked ambivalence about engaging with
other PrEP users in online forums, otherwise noted as a
source of support. Negative representations of PrEP users
dissuaded some non-users from discussing or accessing PrEP.
Internalized stigma was revealed in participants’ narratives
of ambivalence and shame about using PrEP: “I do feel embar-
rassed to tell that I’m on PrEP” (P18, PrEP user, 31 years).
Non-users also recounted internalized stigma reflecting nega-
tive societal attitudes towards GBM’s sexuality more broadly.
PrEP users also reported enacted stigma: “When I talk with
gay men, it usually starts off with, ‘You’re a slut; is that why
you’re on it?’” (P10, PrEP user, 27 years). Non-users similarly
reported enacted stigma when engaging in conversations
about their consideration of PrEP use. Multiple forms of
stigma impacted on PrEP non-users and users across the
PrEP cascade.
3.12 | Impact of PrEP on sexual practices and
relationships
Participant narratives invoked the broader impact of PrEP,
beyond the cascade, on sexual decision-making, negotiations
and relationships. A core representation of PrEP was the equa-
tion of empowerment and choice with condomless sex: “Yeah, I
guess that’s the beauty of PrEP; it empowers us to actually
state what kind of sex we want. Without that condom, condom,
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condom, condom” (P12, PrEP user, 42 years). Another partici-
pant described his evolution along this continuum:
I was in disbelief for a really long time, that it was actu-
ally going to work. I was of the mind that, well, I’ll take it,
but I’ll still continue to use condoms in specific situations.
But that faded really quickly and I started having a lot of
bareback sex. It became my default (P11, PrEP user,
33 years)
Both PrEP-experienced and PrEP-na€ıve participants described
challenges in navigating sexual relationships in the context of
PrEP. From a PrEP user’s perspective, “Now if I’m talking to
two people, one of them says condom and the other one
doesn’t, it’s 99% that I’ll go with the one who says no con-
doms” (P27, PrEP user, 37 years). Non-users described experi-
ences of being encouraged not to use condoms, often ending
with rejection from PrEP users:
. . .we were about to close the deal, and then the disclosure
would come from these folks that they were on
PrEP. . .would I like to have sex with them without a con-
dom? Immediately it was totally cut-off, and it threw me a
little bit (P1, non-user, 33 years).
Another narrative emerged around STIs, with some PrEP
users describing relative lack of concern about STIs in con-
trast to HIV infection: “The concern was that I’d get more
STIs. I did, but it still wasn’t worth not being on PrEP” (P23,
PrEP user, 38 years).”
4 | DISCUSSION
This in-depth exploration of GBM’s perspectives and experi-
ences in encountering and negotiating PrEP use – in the clinic
and in the community – invokes elements of a PrEP cascade,
with challenges and opportunities at various stages; however,
it also reveals substantial gaps in the cascade. The application
of a linear continuum of care to understand PrEP use/non-use
overlooks alternate trajectories and goals for PrEP use, and
may deemphasize psychological/affective, interpersonal, social
and community phenomena that impact on PrEP implementa-
tion and the broader psychological and sexual health of GBM.
Our findings reveal challenges to the conceptualization of a
PrEP user/non-user binary, as well as PrEP use trajectories
that do not map onto a linear cascade or culminate in a goal
of multi-year use and retention in care [8,19,30]. PrEP users
and non-users largely expressed similar sexual practices, but
for the most part only PrEP users perceived themselves as
engaging in high-risk sexual practices that warranted PrEP
use. Low perception of HIV risk among those considered
objectively at high risk has been described as a principal bar-
rier to PrEP uptake [42]. However, we identified other motiva-
tions for PrEP use, including the opportunity to safely
decrease condom use in order to enhance sexual pleasure and
that of reducing the widespread psychological burden of HIV-
related anxiety. These motivations underscore participants’
focus on sexual and psychological wellbeing, in addition to
physical wellbeing (i.e. reduced HIV vulnerability), corroborat-
ing other emerging research with PrEP users [16,43-45].
PrEP “non-users” in our study were situated at various posi-
tions, from staunchly against PrEP use to considering PrEP in
the present or for the future. Although this may appear to
mirror the early stages of change in the transtheoretical
model [46], which has been applied to understand PrEP
uptake [14], it is vital for practitioners and researchers to
understand and respect that PrEP uptake is not a desired or
viable option for all GBM, regardless of sexual practices.
Further complicating the “cascade,” among GBM considered
“PrEP users,” one decided to access PrEP but did not fill his
prescription; others initiated PrEP but then discontinued; and,
of these, some re-initiated PrEP and others did not. Becoming
or staying adherent were not universal goals; rather, partici-
pants revealed ongoing decision-making about whether to
take and remain on PrEP based on dynamic sexual risk and
relationship trajectories. Many participants saw themselves as
being on PrEP for a finite amount of time, indicating the
shortcomings of analogizing PrEP for HIV-negative people to
antiretroviral medication for people living with HIV and an
HIV continuum of care. “Retention in PrEP care” appears not
to be an accurate representation of the end stage (or “suc-
cess”) of the PrEP cascade; rather, PrEP discontinuation and
various permutations of seasonal or intermittent use [8,47]
were also desired goals.
Among the potent psychosocial phenomena revealed was
the impact of PrEP in freeing GBM from decades-long anxiety
about HIV that had pervaded their sexual and social words
[19,31,32,43,48]; this may be difficult to capture in quantita-
tive metrics designed to assess progress along the PrEP cas-
cade. Nevertheless, this affective dimension is likely to
influence GBM’s encounters with PrEP, from awareness, to
decision-making about initiation, to adherence and retention.
A second psychosocial dimension was acute awareness of PrEP
stigma and its impact across the cascade [26,27,30,32,44]. To the
extent stigma is not depicted as a social phenomenon
throughout the cascade, this may result in missed opportuni-
ties to mitigate foreseeable obstacles to PrEP access, initiation
and adherence; it also may exacerbate individual GBM’s inter-
nalization of stigma (due to its being constructed as an indivi-
dual rather than a social-structural problem), with negative
impacts on psychological and sexual health.
Third, we identified the potential for shifts in sexual prac-
tices that present new challenges for risk reduction
approaches, including sexual negotiation and seroadaptive
strategies [49], which have become GBM community norms
for two decades. We did not identify extensive changes in the
sexual practices of individual GBM post-PrEP initiation, similar
to other investigations [19,31,35,44] – most participants were
already using condoms inconsistently. However, a number of
emerging tensions were evoked in GBM’s sexual practices and
negotiation. These included experiences of increased pressure
to engage in condomless anal sex – among both PrEP users
and non-users, increased challenges in negotiating condom
use, and perceived increases in rejection by potential sexual
partners of those GBM who insisted on using condoms.
Future research involving PrEP-experienced and PrEP-
na€ıve GBM is necessary to understand how PrEP may be
best represented and implemented in the service of empow-
ering GBM, both those who choose to adopt PrEP
[45,48,50] and those who do not, with the aim of promot-
ing sexual agency and community health. Our findings affirm
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those of recent qualitative studies with PrEP-na€ıve GBM
and HIV-positive GBM that illustrate how PrEP may foment
fault-lines within GBM communities along an HIV-positive/
HIV-negative sero-divide, and the shortcomings of techno-
logically mediated approaches to HIV prevention that fail to
meaningfully engage with GBM’s lived experience [24,51]; in
the present study with GBM PrEP users and non-users, we
identified inchoate schisms along a PrEP user/non-user
divide. Significantly, a unilateral biomedical approach to PrEP
(e.g. “getting drugs into bodies” [21]) risks equating empow-
erment and sexual health solely with PrEP uptake – rather
than with making one’s own informed choices – and thereby
may alienate those GBM who do not find PrEP a desirable
option from public health and HIV preventive interventions,
and GBM from each other.
Based on our findings, we propose an expanded PrEP cas-
cade which incorporates (1) multiple/alternative trajectories of
PrEP use, and (2) psychosocial, interpersonal and community-
level challenges that may be anticipated as PrEP is introduced
and rolled out (see Figure 1). Explicit acknowledgement of
foreseeable psychosocial and community challenges among
GBM in considering and encountering PrEP may contribute to
mitigating PrEP stigma; to supporting re-tooled harm reduc-
tion strategies; and to facilitating communication at interper-
sonal and community levels, with opportunities for targeted
programmes and policies to support GBM’s sexual and psy-
chosocial health – not merely PrEP use.
4.1 | Strengths and limitations
This is among the first qualitative studies to include both PrEP-
experienced and PrEP-na€ıve community-recruited GBM in
exploring experiences and psychosocial considerations affecting
PrEP decision-making and sexual relationships in the PrEP era.
Figure 1. An augmented PrEP cascade incorporating alternate decision-making and endpoints, and psychosocial challenges, among gay,
bisexual and other men who have sex with men.
PrEP, pre-exposure prophylaxis.
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The relatively small sample of GBM recruited in one urban cen-
tre, known to be welcoming of sexual minorities, suggests caution
in generalizing the findings to GBM in smaller or less accepting
communities; however, they may be transferable to urban GBM
in other high-income countries. This study was begun pre-licen-
sure of PrEP in Canada. Contrary to a US-based qualitative study
which identified some participants' hesitancy to use PrEP pre-
FDA approval[25], this did not emerge in our study, perhaps due
to the earlier US approval. However, lack of licensure may have
presented barriers to uptake due to the unavailability of insur-
ance coverage.
5 | CONCLUSIONS
This study suggests the need for an expanded “PrEP cascade”
that addresses dynamic behavioural risks which may benefit
from seasonal or intermittent use, systemic barriers in access
to and sustaining PrEP use and an end goal of terminating
PrEP. An integrated PrEP cascade that incorporates GBM’s
lived experiences, evolving preferences, and psychosocial and
community-level challenges, in alignment with a combination
prevention model, may more effectively promote PrEP imple-
mentation, and GBM’s broader sexual and psychological health.
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APPENDIX 1
Appendix 1. Key themes, dimensions and exemplar quotations from gay, bisexual and other men who have sex with men in Tor-
onto, Canada (N = 29), October 2015 to March 2016
Themes and
dimensions Exemplar quotations
1. HIV risk behaviours
Inconsistent condom
use/dislike condoms
“. . .For me, condoms sometimes either broke and made me really upset and worried. Some other times, I have to




“Well, it was I would say 50-50 depending on how I felt, the level of comfort that I had, or the other person may
have certain concerns. Yeah, it was about 50-50, condoms versus no condoms.” (P7, PrEP user, 45 years)
Consistent condom
use
“Well, I also don’t have a baseline for condomless intercourse, I didn’t, so I didn’t have any feeling of missing out on
anything, or what have you, so condom usage for me as a top wasn’t a problem, and condom usage in a
relationship to me as a bottom, well, that was simply mandatory. If you don’t want to use a condom with me, I’m
sorry, I’m not going to be bottoming for you bareback.” (P17, Non-user, 36 years)
2. HIV risk awareness
HIV anxiety “I have had anxiety for a couple of years now, and part of that is I would constantly worry about getting cancer,
getting HIV. So, even times when I was safe, there would be something in the back of my mind like, ‘what if?’” (P22,
PrEP user, 23 years)
HIV anxiety/
ambivalence
“So, as soon as something happens that’s risky and, quite frankly, feels good, the next thought is well, I’ve got a cough,
I’ve got a cold. Am I positive?” (P10, PrEP user, 27 years)
STI risk concern “. . .Yeah, I could potentially have bareback sex, but PrEP isn’t going to protect me from all the other STIs out there,
and now I’m learning that some of them are much more easily transmitted than HIV. So, that’s a challenging point
for me.” (P4, non-user, 24 years)







“To be honest it was like, really, we are going to start taking a pill now to prevent ourselves from getting HIV? And I
saw it as almost like a Russian roulette approach to having unprotected, risky sex. . ..” (P13, non-user, 38 years)




“So, I read about it for a while but I really only started thinking about it last year, relevantly, if it might be relevant to




“It’s an ongoing process. It’s not just, I woke up one morning, I think I’m going to take PrEP now. It’s more of a, over
the years, I’ve learned more about PrEP through research, talked to a lot of people, talked to people who work in
this field, who are using it as well.” (P12, PrEP user, 42 years)
Not considering PrEP “If I was considering it, I’d probably do some more serious research on it. . ..” (P5, non-user, 47 years)
4. PrEP access
Inaccessible/high cost “. . . Well, the cost would have been such that it would have been inaccessible to me so I really didn’t consider it on
any kind of basis” (P17, non-user, 36 years)
Covered by insurance “And, thankfully, I have coverage through work. I was able to get my medication covered. It’s over $1,000 a month, so




“Now that I’m in the process of losing my job and my insurance benefits and finding out new benefits and all that
kind of stuff, it’s really quite interesting that that administrative process forces you into this whole, holy crap, what
could happen to my health in the next year?” (P10, PrEP user, 27 years)
5. Linkage to PrEP care
No perceived
obstacles/gay doctor
“He’s a gay doctor. I’ve talked to him about lots of stuff. I would have no problem asking him. He’d probably just, oh
really, okay. What’s going on?” (P5, non-user, 47 years)
Preference for gay
doctor
“I mean doctors are not supposed to judge you obviously, but at the same time I would like to talk to someone who
knows what I’m going through. I don’t have to explain certain things to him before he can give me his professional
opinion. No, it’s great. I tell people when they ask me about PrEP, I tell them, do you have a gay doctor, you really
need to find a gay doctor. I’m sure yours is great, but only a gay doctor would really understand, once again in my





“It was kind of a cool experience, I guess, just leaving there like. . .” (P10, PrEP user, 30 years)
Streamlined process “. . .when I eventually did go in, it was really straightforward. . . conversation about why I wanted to take it, what I
knew about it, and then do the blood work and that kind of stuff. It was easily within a month of bringing it up, to
getting started” (P20, PrEP user, 30 years)
Positive experience
with pharmacist
“She was actually very cool about it. . .Her pharmacy is right in the gay village.” (P19, PrEP user, 48 years)
“The pharmacist that I see is well-versed in PrEP. . .and the [pharmacy] deals specifically in HIV medication every




“So many months had led up to it and it was like finally I’ve taken my first step. I first heard about this in late 2014
and early 2015, and now it’s getting close to late 2015.” (P22, PrEP user, 23 years)
Happiness “[I did the] first pill selfie and 90-day check-in, yeah. . .I felt pretty happy.” (P10, PrEP user, 30 years)
“Non-event” “[it was] a complete non-event, it was just a pill.” (P14, PrEP user, 42 years)
Rumination “I went through. . .I sat down in my room, and I thought. . .I remember thinking if it was the right thing to do.” (P18,
PrEP user, 31 years)
8. Adherence to PrEP
Missed dose “Sometimes the day gets away from you, and I would forget.” (P24, PrEP user, 31 years)
Intermittent use as
challenging
“But, the problem is there seems to be no clear consensus as to how to take it if you’re doing that [taking it
intermittently]. So, I’d rather just not risk it.” (P22, PrEP user, 23 years)
Strategies for
adherence
“. . .I made a schedule. I made an alarm. I made a plan that I have to take my pills before 10:00 with my alarm. So,
that makes a very annoying sound. And it doesn’t matter if I would be at work or wherever. I have to cut
everything and take my pill and then turn it off.” (P3, PrEP user, 39 years)









“That’s another thing too is that I’m guaranteed to go get tested for everything every three months, whereas before
maybe every six months it was happening or so. So, it forces me to get tested, which if I do have anything, I can kill
it pretty quick.” (P22, PrEP user, 23 years)
Time-limited use “Yeah I told my partner, I said I really didn’t want to take it for more than a year continuously. I really don’t want to.”
(P19, PrEP user, 48 years)
Routinization of care “Every three months, yeah, I get them pre-printed in advance. He gives me all my lab requisitions, so I just go in and
do them the week before and then I go in and get swabs and all of that.” (P10, PrEP user, 27 years)
10. PrEP stigma
Felt-normative stigma “There was one big conversation I had with a friend about a mutual friend, who we found out publicly was on PrEP,
and both of us were like, ‘what?’ The first thing is, ‘well, of course, they’re on it. You know what they’re into, right?’”
(P2, non-user, 38 years)
Vicarious stigma “The internet and the apps are opportunities to be really cruel for many people, and I have seen language used
around, ‘oh, silly faggot taking loads, get some self-respect’, those sorts of things.” (P1, non-user, 33 years)
Enacted stigma “He [a friend online] was very judgmental in terms of coming down on people who choose to bareback and are taking
PrEP as a preventative measure. His post was ‘people [on PrEP] are disgusting,’ this and that. I said, listen, I
bareback and I don’t think I’m a disgusting, horrible person, so I don’t understand why this is an issue when you
consider me to be your friend.” (P7, PrEP user, 45 years)
Internalized stigma “Knowing myself, if I was to take PrEP my behaviour would change. A friend that isn’t on it, said I would just be the
biggest cum slut out there if that was the case.” (P5, non-user, 47 years)
“I don’t put it on my profile. But, I tell people if I think it helps.” (P22, PrEP user, 23 years)
“I do feel embarrassed to tell that I’m on PrEP. Even with the person that I’m seeing now. . . So I guess there is a
little bit of shame in me.” (P18, PrEP user, 31 years)
11. Impact of PrEP on sexual practices and relationships
Pressure not to use
condoms
“. . .I’d say it was like a year ago or so the pressure to have sex bare, it’s like overnight and like through the roof.”
(P14, PrEP user, 42 years)
Condomless sex as
norm
“Right, because I really haven’t met anybody yet that takes PrEP and hasn’t asked me to do bareback sex. Usually it




“. . .we were about to close the deal, and then the disclosure would come from these folks that they were on
PrEP. . .would I like to have sex with them without a condom? I said well, the guideline that I have with my man is
that we use condoms when we’re having sex outside our relationship. Immediately it was totally cut-off, and it
threw me a little bit.” (P1, non-user, 33 years)
STIs as relatively
inconsequential
“. . . I think the other STDs like gonorrhea, chlamydia, like syphilis, they’re in a way curable. . . You get something, you
get an antibiotic, you go home and you survive.” (P26, PrEP user, 34 years)
PrEP, pre-exposure prophylaxis; STDs, sexually transmitted diseases; STIs, sexually transmitted infections.
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